Skip to main content
OpenTrials

Clinical trial condition

Digestive System Neoplasms

Explore clinical trials studying Digestive System Neoplasms. Study availability and eligibility vary by location and protocol.

14,203 public trials 3,225 recruiting studies
Refine in advanced search Browse all conditions

Digestive System Neoplasms trial results

Recruiting

A Study of Response to Standard Treatment Before Surgery in People With Rectal Cancer

NCT06637462

Conditions
Adenocarcinoma of the Rectum, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Suffolk - Commack (Limited Protocol Activities) Commack, New York, United States
  • Memorial Sloan Kettering Westchester (Limited protocol activities) Harrison, New York, United States
View Trial Details
Recruiting

Confronting Cancer as a Community

NCT06063928

Conditions
Colonic Diseases, Colorectal Carcinoma, Colorectal Neoplasms, +9 more
Locations
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View Trial Details
Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

NCT06917079

Conditions
Advanced Lung Carcinoma, Bronchial Neoplasms, CRC (Colorectal Cancer), +34 more
Locations
  • The Angeles Clinic and Research Institute - West Los Angeles Office Los Angeles, California, United States
  • University of California Davis Sacramento, California, United States
  • University of California San Diego Moores Cancer Center San Diego, California, United States
  • University of California San Francisco Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
View all 17 locations
View Trial Details
Recruiting

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

NCT07197554

Conditions
Adenocarcinoma, Advanced Solid Tumors, Biliary Tract Cancer (BTC), +30 more
Locations
  • The City of Hope National Medical Center Duarte, California, United States
  • Hoag Memorial Hospital Newport Beach, California, United States
  • Mass General Brigham Cancer Institute Boston, Massachusetts, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing

NCT04981119

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +65 more
Locations
  • Banner Health Gilbert, Arizona, United States
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • University of California San Diego La Jolla, California, United States
View all 16 locations
View Trial Details
Recruiting

INTERACT Stomach-II

NCT07133490

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +6 more
Locations
  • Antoni van Leeuwenhoek Amsterdam, Netherlands
  • Catharina Hospital Eindhoven, Netherlands
  • Erasmus MC, University Medical Center Rotterdam Rotterdam, Netherlands
View Trial Details
Recruiting

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

NCT06607458

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +10 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Hematology/Oncology-Santa Monica Santa Monica, California, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Kansas Clinical Research Center Fairway, Kansas, United States
View all 14 locations
View Trial Details

Related conditions